|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 504 active entries
Im Neuenheimer Feld 584
Phone: +49 (0)6221 1370 810
Fax: +49 (0)6221 1370 829
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Gene Bridges GmbH is a self-financed biotechnology company pioneering “recombineering”, a scientific approach that allows site-specific and size-independent cloning/DNA modification. The Company’s Red/ET™ Recombination technology is a patent-protected recombineering technology that enables researchers the freedom to design and experiment in transgenics, E.coli chromosome modification and many other areas of genetic modification.
Commercial licenses are readily available to use the technology and Gene Bridges provides recombineering services and also ready-to-use recombineering kits for academic research. The Company is privately held and was founded in 2000 as spin-off from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Further information on Gene Bridges can be found at www.genebridges.com
Last update of this entry: September 27, 2017